This month has brought a holiday rush of hemophilia news on potential new treatments, studies, and acquisitions — all of which serve to raise hope during this solstice season, as ... Read more

Takeda has presented new real-world data to support the cost-effectiveness and persistent benefits to patients of its hemophilia A and B therapies: Adynovate and Feiba ... Read more

As the year draws to a close, I cannot help but review the successes and failures of the past 12 months. How do I continue to honor the many ... Read more

As I look back on where I was at this time last year, I can honestly say that 2019 has been a fantastic year. My health has improved tremendously. ... Read more

Takeda has presented early data on the prevalence of — and a possible solution for — one of gene therapy’s main hurdles: the development of an immune reaction against the ... Read more

I love the holidays — candlelight, decorations, the smell of baking, and time with family. I look forward to the holidays every year, but I am also keenly aware ... Read more

To help promote healthy lifestyle changes, the pharmaceutical company Takeda has enrolled some 900 patients with bleeding disorders like hemophilia in the Virgin Pulse Global Challenge. The annual well-being Global ... Read more

I am scrambling to find my way back to a schedule that includes time to write and research. For some reason, I am finding it difficult to get motivated. ... Read more

With Christmas only a few weeks away, Hemophilia Association of the Philippines for Love and Service (HAPLOS) threw its annual Christmas party. It’s a modest event, but seeing people ... Read more

The holiday season brings happiness and joy to many. Homes are adorned with lights and decorations, and people wear clothing in festive colors. The excitement is contagious. However, many ... Read more